Insider · CIK 0002007835
Brian Guan-Chyun Liu
director
Files at CGON (CG Oncology, Inc.). First filing Sep 15, 2025, latest Sep 15, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$50M bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CGON: CG Oncology, Inc.
CGONOct 9, 2026 · close 63.82
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | CG Oncology, Inc. | $50M 1,515,151 shares | - | +113% from low-17% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | CGON CG Oncology, Inc. | POpen-market purchase Common Stockindirect: By Seven Fleet Partners LP10b5-1 | +1,515,151 | $33.00 | $50M | 1,515,151 | Sep 15, 2025 |
| Jun 5, 2025 | CGON CG Oncology, Inc. | AGrant or award Director Stock Option (right to buy)derivative10b5-1 | +24,165 | $0.00 | $0 | 24,165 | Jun 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.